Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

191 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Therapy of membranous nephropathy in systemic lupus erythematosus.
Balow JE, Austin HA 3rd. Balow JE, et al. Semin Nephrol. 2003 Jul;23(4):386-91. doi: 10.1016/s0270-9295(03)00056-1. Semin Nephrol. 2003. PMID: 12923727 Review.
Chronic granulomatous disease as a risk factor for autoimmune disease.
De Ravin SS, Naumann N, Cowen EW, Friend J, Hilligoss D, Marquesen M, Balow JE, Barron KS, Turner ML, Gallin JI, Malech HL. De Ravin SS, et al. J Allergy Clin Immunol. 2008 Dec;122(6):1097-103. doi: 10.1016/j.jaci.2008.07.050. Epub 2008 Sep 26. J Allergy Clin Immunol. 2008. PMID: 18823651 Free PMC article.
Safety and Tolerability of Omalizumab: A Randomized Clinical Trial of Humanized Anti-IgE Monoclonal Antibody in Systemic Lupus Erythematosus.
Hasni S, Gupta S, Davis M, Poncio E, Temesgen-Oyelakin Y, Joyal E, Fike A, Manna Z, Auh S, Shi Y, Chan D, Carlucci P, Biehl A, Dema B, Charles N, Balow JE, Waldman M, Siegel RM, Kaplan MJ, Rivera J. Hasni S, et al. Among authors: balow je. Arthritis Rheumatol. 2019 Jul;71(7):1135-1140. doi: 10.1002/art.40828. Epub 2019 May 8. Arthritis Rheumatol. 2019. PMID: 30597768 Free PMC article. Clinical Trial.
Randomized, controlled trial of prednisone, cyclophosphamide, and cyclosporine in lupus membranous nephropathy.
Austin HA 3rd, Illei GG, Braun MJ, Balow JE. Austin HA 3rd, et al. J Am Soc Nephrol. 2009 Apr;20(4):901-11. doi: 10.1681/ASN.2008060665. Epub 2009 Mar 18. J Am Soc Nephrol. 2009. PMID: 19297556 Free PMC article. Clinical Trial.
Tocilizumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study.
Illei GG, Shirota Y, Yarboro CH, Daruwalla J, Tackey E, Takada K, Fleisher T, Balow JE, Lipsky PE. Illei GG, et al. Among authors: balow je. Arthritis Rheum. 2010 Feb;62(2):542-52. doi: 10.1002/art.27221. Arthritis Rheum. 2010. PMID: 20112381 Free PMC article. Clinical Trial.
Clinical presentation and monitoring of lupus nephritis.
Balow JE. Balow JE. Lupus. 2005;14(1):25-30. doi: 10.1191/0961203305lu2055oa. Lupus. 2005. PMID: 15732284 Review.
Progress in the treatment of proliferative lupus nephritis.
Balow JE, Austin HA 3rd. Balow JE, et al. Curr Opin Nephrol Hypertens. 2000 Mar;9(2):107-15. doi: 10.1097/00041552-200003000-00003. Curr Opin Nephrol Hypertens. 2000. PMID: 10757214 Review.
New prospects for treatment of lupus nephritis.
Balow JE, Boumpas DT, Austin HA 3rd. Balow JE, et al. Semin Nephrol. 2000 Jan;20(1):32-9. Semin Nephrol. 2000. PMID: 10651216 Review.
Angiotensin I converting enzyme gene polymorphisms in systemic lupus erythematosus: decreased prevalence of DD genotype in African American patients.
Tassiulas IO, Aksentijevich I, Salmon JE, Kim Y, Yarboro CH, Vaughan EM, Davis JC, Scott DL, Austin HA, Klippel JH, Balow JE, Gourley MF, Boumpas DT. Tassiulas IO, et al. Clin Nephrol. 1998 Jul;50(1):8-13. Clin Nephrol. 1998. PMID: 9710341
191 results
Jump to page